IL-10 control of dendritic cells in the skin

OncoImmunology

Volumn 2, Issue 3, 2013, Pages

  Clausen, Björn E ^a,b   Girard Madoux, Mathilde J H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Conditional gene targeting; Contact hypersensitivity; Dendritic cells; IL 10 receptor signaling; Immune regulation; Interleukin 10; Langerhans cells; Skin

Indexed keywords

HAPTEN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CELL SPECIFICITY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE DELETION; HOMEOSTASIS; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STEADY STATE;

EID: 84886943833     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23186     Document Type: Article

References (10)

1. Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008; 28:468-76; PMID: 18400189; DOI: 10.1016/j.immuni.2008.03.003.
2. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10:170-81; PMID: 20154735; DOI: 10.1038/nri2711.
3. Berg DJ, Leach MW, Kühn R, Rajewsky K, Müller W, Davidson NJ, et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995; 182:99-108; PMID: 7790826; DOI: 10.1084/jem.182.1.99.
4. Vocanson M, Hennino A, Rozières A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009; 64:1699-714; PMID: 19839974; DOI: 10.1111/j.1398-9995.2009.02082.x.
5. Roers A, Siewe L, Strittmatter E, Deckert M, Schlüter D, Stenzel W, et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med 2004; 200:1289-97; PMID: 15534372; DOI: 10.1084/jem.20041789.
6. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28:546-58; PMID: 18387831; DOI: 10.1016/j.immuni.2008.02.017.
7. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449:419-26; PMID: 17898760; DOI: 10.1038/nature06175.
8. Noordegraaf M, Flacher V, Stoitzner P, Clausen BE. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J Invest Dermatol 2010; 130:2752-9; PMID: 20703247; DOI: 10.1038/jid.2010.223.
9. Igyarto BZ, Jenison MC, Dudda JC, Roers A, Müller W, Koni PA, et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol 2009; 183:5085-93; PMID: 19801524; DOI: 10.4049/jimmunol.0901884.
10. Girard-Madoux MJ, Kel JM, Reizis B, Clausen BE. IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity. J Allergy Clin Immunol 2012; 129:143-50, e1-10; PMID: 21975175; DOI: 10.1016/j.jaci.2011.08.032.